Patents by Inventor Huawei ZHU

Huawei ZHU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11517606
    Abstract: The present invention relates to a composition having an anti-glycation effect and an application thereof. The anti-glycation composition includes the following constituents in parts by mass: 0.1 to 5 parts of Osmanthus fragrans extract, 0.1 to 5 parts of Punica granatum extract and 0.1 to 2 part of Olea europaea extract, wherein in the Osmanthus fragrans extract, a mass content of polyphenol is more than or equal to 10%, and a mass content of verbascoside is more than or equal to 10%; in the Punica granatum extract, a mass content of polyphenol is more than or equal to 30%, and a mass content of punicalagin is more than or equal to 8%; and in the Olea europaea extract, a mass content of polyphenol is more than or equal to 10%, and a mass content of hydroxytyrosol is more than or equal to 3%.
    Type: Grant
    Filed: December 11, 2019
    Date of Patent: December 6, 2022
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Xiaoling Wang, Huawei Zhu, Zhen Luo, Jian Tang
  • Publication number: 20210106642
    Abstract: The present invention relates to a composition having an anti-glycation effect and an application thereof. The anti-glycation composition includes the following constituents in parts by mass: 0.1 to 5 parts of Osmanthus fragrans extract, 0.1 to 5 parts of Punica granatum extract and 0.1 to 2 part of Olea europaea extract, wherein in the Osmanthus fragrans extract, a mass content of polyphenol is more than or equal to 10%, and a mass content of verbascoside is more than or equal to 10%; in the Punica granatum extract, a mass content of polyphenol is more than or equal to 30%, and a mass content of punicalagin is more than or equal to 8%; and in the Olea europaea extract, a mass content of polyphenol is more than or equal to 10%, and a mass content of hydroxytyrosol is more than or equal to 3%.
    Type: Application
    Filed: December 11, 2019
    Publication date: April 15, 2021
    Applicant: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Xiaoling WANG, Huawei ZHU, Zhen LUO, Jian TANG
  • Patent number: 10869948
    Abstract: Disclosed is a composition of a collagen peptide and an elastin peptide, method of producing the same and use thereof. The composition of the present disclosure consists of a collagen peptide and an elastin peptide; the collagen peptide is prepared by enzymatic hydrolysis of a collagen material with pepsin or trypsin, and the elastin peptide is prepared by enzymatic hydrolysis of an elastin material with papain and/or protease Protamex. In the present disclosure, an elastin peptide and a collagen peptide with molecular weight in a specific range are prepared by specific processes, and the composition composed of the two at a suitable ratio can simultaneously and significantly increase the amount of the elastin and collagen in a damaged skin in a small usage amount, and significantly increase the content of hyaluronic acid and hydroxyproline while decrease the content of MMP3, meanwhile, inhibit skin inflammatory factors.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: December 22, 2020
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Huawei Zhu, Xiaoling Wang, Liugang Ding, Xiaolei Guo, Yazhong Ge
  • Publication number: 20200222585
    Abstract: Disclosed is a composition of a collagen peptide and an elastin peptide, method of producing the same and use thereof. The composition of the present disclosure consists of a collagen peptide and an elastin peptide; the collagen peptide is prepared by enzymatic hydrolysis of a collagen material with pepsin or trypsin, and the elastin peptide is prepared by enzymatic hydrolysis of an elastin material with papain and/or protease Protamex. In the present disclosure, an elastin peptide and a collagen peptide with molecular weight in a specific range are prepared by specific processes, and the composition composed of the two at a suitable ratio can simultaneously and significantly increase the amount of the elastin and collagen in a damaged skin in a small usage amount, and significantly increase the content of hyaluronic acid and hydroxyproline while decrease the content of MMP3, meanwhile, inhibit skin inflammatory factors.
    Type: Application
    Filed: May 16, 2019
    Publication date: July 16, 2020
    Applicant: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Huawei ZHU, Xiaoling WANG, Liugang DING, Xiaolei GUO, Yazhong GE
  • Patent number: 10646534
    Abstract: The present invention belongs to the field of Chinese herbal medicine products, and more particularly relates to a formulation, preparation method and use of a Chinese herbal medicine composition for soothing the liver. The present invention provides a Chinese herbal medicine composition for soothing the liver, wherein the raw materials of the composition comprise Rhizoma Cyperi, Radix Angelicae Sinensis, Rhizoma Ligustici Chuanxiong, Radix Paeoniae Alba, and Pericarpium Citri Reticulatae. The present invention further provides a preparation method of the composition, comprising: step 1, extracting; step 2, concentrating; and Step 3, drying. Moreover, the present invention provides the use of the composition and the product obtained by the method in the treatment of a breast disease and/or remission of depression.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: May 12, 2020
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Shuo Liu, Huawei Zhu, Yiting Yang, Chung Wah Ma
  • Patent number: 10105408
    Abstract: The present invention relates to the field of traditional Chinese medicine formulation, particularly to a composition and the preparation method and use thereof. The traditional Chinese medicine composition provided by the present invention is produced from raw materials comprising TARAXACI HERBA, GLYCYRRHIZAE RADIX ET RHIZOMA, PLATYCODONIS RADIX, CITRI RETICULATAE PERICARPIUNM and PHYLLANTHI FRUCTUS. The traditional Chinese medicine composition adopts fewer herb medicines. By reasonable combination, the various herbal medicines mutually reinforce in terms of the effects of clearing throat, anti-inflammation and reducing phlegm, exhibit obvious synergistic effect. Pharmacological tests and clinical trials indicate that the traditional Chinese medicine composition has significant throat clear, anti-inflammatory, expectorant effects (p<0.05), and has no obvious toxic and side effects.
    Type: Grant
    Filed: April 10, 2017
    Date of Patent: October 23, 2018
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Huawei Zhu, Jialing Ning, Yiting Yang, Shuo Liu, Chung Wah Ma
  • Publication number: 20180085416
    Abstract: The present invention relates to the field of traditional Chinese medicine formulation, particularly to a composition and the preparation method and use thereof. The traditional Chinese medicine composition provided by the present invention is produced from raw materials comprising TARAXACI HERBA, GLYCYRRHIZAE RADIX ET RHIZOMA, PLATYCODONIS RADIX, CITRI RETICULATAE PERICARPIUNM and PHYLLANTHI FRUCTUS. The traditional Chinese medicine composition adopts fewer herb medicines. By reasonable combination, the various herbal medicines mutually reinforce in terms of the effects of clearing throat, anti-inflammation and reducing phlegm, exhibit obvious synergistic effect. Pharmacological tests and clinical trials indicate that the traditional Chinese medicine composition has significant throat clear, anti-inflammatory, expectorant effects (p<0.05), and has no obvious toxic and side effects.
    Type: Application
    Filed: April 10, 2017
    Publication date: March 29, 2018
    Applicant: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Huawei ZHU, Jialing NING, Yiting YANG, Shuo LIU, Chung Wah MA
  • Publication number: 20180028588
    Abstract: The present invention belongs to the field of Chinese herbal medicine products, and more particularly relates to a formulation, preparation method and use of a Chinese herbal medicine composition for soothing the liver. The present invention provides a Chinese herbal medicine composition for soothing the liver, wherein the raw materials of the composition comprise Rhizoma Cyperi, Radix Angelicae Sinensis, Rhizoma Ligustici Chuanxiong, Radix Paeoniae Alba, and Pericarpium Citri Reticulatae. The present invention further provides a preparation method of the composition, comprising: step 1, extracting; step 2, concentrating; and Step 3, drying. Moreover, the present invention provides the use of the composition and the product obtained by the method in the treatment of a breast disease and/or remission of depression.
    Type: Application
    Filed: January 20, 2017
    Publication date: February 1, 2018
    Applicant: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Shuo LIU, Huawei ZHU, Yiting YANG, Chung Wah MA